Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colistin + sulbactam versus colistin + sulbactam + high-dose tigecycline for carbapenem-resistant Acinetobacter baumannii pneumonia
TCTR20241218002Phase 4Not yet recruiting
- Sponsor
- Phramongkutklao Hospital
- Start
- Dec 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of colistin, sulbactam, tigecycline in pneumonia, sponsored by Phramongkutklao Hospital. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
colistinsulbactamtigecycline
03
Conditions
pneumonia
Beyond the preview
Go deeper on TCTR20241218002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20241218002.